Dudediligence.

Impact BioMedical Inc

IBOAMEX · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$7,000Jun ’25$18,000Sep ’25$7,000Dec ’25$7,000Mar ’26$3,000Jun ’26
Net income, by quarter
$4.2MSep ’24−$27.1MDec ’24−$1.3MMar ’25−$14.3MJun ’25−$1.5MSep ’25$5.2MDec ’25−$2.3MMar ’26−$699,000Jun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Revenue$50,000none on filenone on file$32,000
Gross profitnone on filenone on filenone on file−$392,000
Operating income−$3.4M−$4.0M−$28.8M−$4.3M
Net income−$7.3M−$4.3M−$24.7M−$11.8M
Operating cash flow−$2.2M−$2.9M−$2.9M−$1.9M
Cash$2,000$1,000$2.0M$3,000
Shares outstanding70.5M10.0M11.5M104.6M